Inequities in MHT Prescribing Run Deep: A Conversation With Wake Forest's Anna Caroline Cochrane, MD
TMS 2025: Cochrane explains the impetus behind 2 studies she has authored on the patient- and provider-level factors that influence MHT prescribing.
Mayo Clinic Researcher on How Hormone Therapy May Influence Weight Loss Outcomes With Tirzepatide
Brain Changes, Weight Management, and Breast Screening: Essential Updates From TMS 2025
New research from TMS 2025 covers menopause effects on brain volume, hormone therapy's role in weight loss with GLP-1s, and dense breast screening updates.
When Should Mammography Begin? Donna Plecha, MD, on Differing Breast Cancer Screening Guidelines
Early breast cancer screening at age 40, especially with 3D mammograms, significantly improves survival rates and quality of life, according to Dr Plecha.
MHT and Alzheimer Risk: New Evidence for a Critical Window, with Roksana Karim, MD, PhD
Karim discusses secondary findings from the ELITE trial of timing for estradiol initiation, which reveal a notable impact on Aβ biomarkers of Alzheimer disease.
Why Do Women Suffer in Silence with Genitourinary Syndrome of Menopause?
Menopause specialist Caroline Mitchell, MD, MPH, explains the dual nature of the breakdown in communication that can leave women virtually uninformed about GSM and treatment.
Xuezhi Daniel Jiang, MD, PhD, on Counseling Postmenopausal Women on Autoimmune Disease Risk Without Creating Hormone Therapy Phobia
Jiang shares how to use new autoimmune risk data responsibly—identifying high-risk patients while avoiding unnecessary hormone therapy phobia.
Hormone Therapy Linked to Increased Autoimmune Disease Risk
Dr. Daniel Jiang shares unexpected research findings showing hormone therapy increased autoimmune disease risk across 15 of 17 conditions in postmenopausal women.
Hormone Therapy and Autoimmune Disease Risk in Postmenopausal Women, With Xuezhi Daniel Jiang, MD, PhD
TMS 2025: Jiang explains why he investigated hormone therapy's effect on autoimmune disease risk in postmenopausal women.
Estetrol Phase 3 Trial Shows No Impact on Postmenopausal BP, Even in Women at High CV Risk
The phase 3 E4COMFORT II trial found no impact on BP after 1 year of treatment in postmenopausal women with elevated HbA1c, lipids, and TGs.
Caroline Mitchell, MD, Describes Toll of Genitourinary Syndrome of Menopause on QoL
TMS: Half of postmenopausal women suffer from GSM, yet only 25% seek treatment. Mitchell, an expert in vulvovaginal health, explains the gap and its impact on women.
FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause
The novel once-daily nonhormonal therapy offers a new option to offer women who prefer not to take HRT or for whom it is contraindicated.
Menopause: A Constellation of Syndromes Across 13 Body Systems
Our short slide show outlines interrelated syndromes of menopause across 13 body systems, implicating therapeutic targets and approaches for clinical practice.
Marla Shapiro, CM, MDCM, on Recognizing Early Perimenopause: Sleep, Mood, and Other Missed Clues
Subtle sleep, mood, and cycle changes may herald perimenopause. Dr. Marla Shapiro discusses how clinicians can recognize and address them early.
Menopause Education Lags in Residency Training Across Primary Care Specialties
Less than one-third of residents in IM, FM, and OB/GYN programs receive structured menopause training, leaving many unprepared for midlife women’s care.
Timing of Menopausal Hormone Therapy May Impact Biomarkers of Alzheimer Disease
A secondary analysis of the ELITE trial suggests that there may be a postmenopausal "critical window" during which use of MHT is optimal.
Menopause Education Wholly Inadequate for Physician Associates, According to New Survey Results
Only 3% of physician associate respondents reported receiving more than 5 hours of menopause-related training during their professional education.
Treating Hot Flashes May Improve Cognitive Symptoms: Study Author Explains the Connection
TMS 2025: Katrina Wugalter, MA, explains why treating vasomotor symptoms may be key to improving cognitive function during menopause.
APOE ε4 and Inflammation Amplify Risk for Memory Decline in Women with Earlier Menopause
Earlier menopause, APOE ε4, and age-related inflammation combine to accelerate memory decline, revealing key factors in women’s Alzheimer disease risk.
Inequities in Menopause Care: How Provider and Patient Factors Combine to Limit Treatment
TMS: Menopause care isn’t one-size-fits-all—and that’s the problem. Wake Forest data reveal deep disparities in who gets treated and how.
